JP4989481B2 - 気管支炎症性疾患の治療及び予防のためのシクロデキストリンの使用 - Google Patents

気管支炎症性疾患の治療及び予防のためのシクロデキストリンの使用 Download PDF

Info

Publication number
JP4989481B2
JP4989481B2 JP2007535148A JP2007535148A JP4989481B2 JP 4989481 B2 JP4989481 B2 JP 4989481B2 JP 2007535148 A JP2007535148 A JP 2007535148A JP 2007535148 A JP2007535148 A JP 2007535148A JP 4989481 B2 JP4989481 B2 JP 4989481B2
Authority
JP
Japan
Prior art keywords
cyclodextrin
treatment
bronchial
compound
cyclodextrins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007535148A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008515847A (ja
Inventor
カタルド、ディディエ
エヴラール、ブリジット
ノエル、アニエス
フォアダール、ジャン・ミシェル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liège
Original Assignee
University of Liège
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liège filed Critical University of Liège
Publication of JP2008515847A publication Critical patent/JP2008515847A/ja
Application granted granted Critical
Publication of JP4989481B2 publication Critical patent/JP4989481B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP2007535148A 2004-10-10 2005-09-30 気管支炎症性疾患の治療及び予防のためのシクロデキストリンの使用 Expired - Fee Related JP4989481B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04104957A EP1655034A1 (de) 2004-10-10 2004-10-10 Verwendung von Cyclodextrin zur Behandlung und Vorbeugung von entzündlichen Bronchialerkrankungen.
EP04104957.8 2004-10-10
PCT/EP2005/054966 WO2006037769A1 (en) 2004-10-10 2005-09-30 Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases.

Publications (2)

Publication Number Publication Date
JP2008515847A JP2008515847A (ja) 2008-05-15
JP4989481B2 true JP4989481B2 (ja) 2012-08-01

Family

ID=34929683

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007535148A Expired - Fee Related JP4989481B2 (ja) 2004-10-10 2005-09-30 気管支炎症性疾患の治療及び予防のためのシクロデキストリンの使用

Country Status (8)

Country Link
US (3) US7829550B2 (de)
EP (2) EP1655034A1 (de)
JP (1) JP4989481B2 (de)
AT (1) ATE456955T1 (de)
DE (1) DE602005019247D1 (de)
ES (1) ES2340511T3 (de)
PL (1) PL1799231T3 (de)
WO (1) WO2006037769A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9545424B2 (en) 2007-06-01 2017-01-17 SolAero Med Inc. Method of treating pulmonary surfactant dysfunction or respiratory distress syndrome by administering cyclodextrin or a derivative thereof
JP2013532734A (ja) * 2010-08-04 2013-08-19 ユニバーシティ オブ バージニア パテント ファウンデーション 炎症性疾患を治療するための組成物及び方法
CA2880880C (en) 2012-08-03 2021-01-26 John Mckew Cyclodextrin for the treatment of lysosomal storage diseases
RU2506080C1 (ru) * 2012-09-25 2014-02-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО НижГМА Минздравсоцразвития России) Способ лечения и профилактики осложнений в полости рта, вызванных приемом ингаляционных гормональных препаратов у больных бронхиальной астмой
AU2012390966B2 (en) * 2012-09-27 2018-07-26 Solaeromed Inc. Treatment of pulmonary surfactant dysfunction using cholesterol-sequestering cyclodextrins
FR3014694B1 (fr) * 2013-12-13 2016-11-11 Roquette Freres Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl
EP4122469A1 (de) * 2014-03-28 2023-01-25 Paul Maes Zusammensetzung mit cyclodextrin und budesonidderivaten zur behandlung und prophylaxe von pulmonalen entzündungen
EP2923702A1 (de) * 2014-03-28 2015-09-30 Universite De Liege Zusammensetzung von Cyclodextrin mit Budesonidderivaten zur Behandlung und Vorbeugung von entzündlichen Lungenerkrankungen
AU2016276774A1 (en) 2015-06-10 2018-01-18 Vtesse, Inc. Hydroxypropyl beta-cyclodextrin compositions and methods
US12522670B2 (en) 2018-06-29 2026-01-13 Roquette Freres Hydroxypropyl-beta-cyclodextrin and process for the production thereof
FR3083234B1 (fr) * 2018-06-29 2020-11-27 Roquette Freres Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation
BE1027425B1 (fr) * 2019-07-01 2021-02-08 Aquilon Pharmaceuticals Composition inhalable comprenant de la cyclodextrine a utiliser dans le traitement d’inflammations nasales
BE1027612B1 (fr) 2019-09-10 2021-05-03 Aquilon Pharmaceuticals Microparticules en forme de balle de golf pour une utilisation dans le traitement et la prevention de maladies pulmonaires
US11045434B1 (en) 2020-04-01 2021-06-29 UNION therapeutics A/S Niclosamide formulations for treating disease
MA53516A1 (fr) * 2020-06-15 2022-04-29 Univ Liege Cyclodextrine utilisée dans le traitement et la prévention de la bronchoconstriction en phase tardive de l'asthme provoqué par des allergènes.
BE1030002B1 (fr) 2021-12-29 2023-09-01 Aquilon Pharmaceuticals Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire
WO2023118014A1 (en) 2021-12-20 2023-06-29 Aquilon Pharmaceuticals Inhalable compositions comprising a complex of hpbcd and budesonide or ciclesonide for the treatment or prevention of a respiratory viral disease or lipopolysaccharide-induced inflammation, in particular lipopolysaccharide-induced inflammation associated with a respiratory viral disease
JP2025506676A (ja) 2022-02-18 2025-03-13 ベレン セラピューティクス ピー．ビー．シー． ヒドロキシプロピル－ベータ－シクロデキストリンの組成物及びその精製方法
BE1031693B1 (fr) 2023-06-07 2025-01-23 Aquilon Pharmaceuticals Compositions sans conservateur comprenant un complexe de corticostéroïde et d'hpbcd pour le traitement ou la prévention d'une maladie inflammatoire par administration nasale
BE1031691B1 (fr) 2023-06-07 2025-01-23 Aquilon Pharmaceuticals Compositions sans conservateur comprenant un complexe de corticostéroïde et d'hpbcd pour le traitement ou la prévention d'une maladie inflammatoire par administration nasale
EP4724038A1 (de) 2023-06-07 2026-04-15 Aquilon Pharmaceuticals Konservierungsmittelfreie zusammensetzungen mit einem komplex aus einem kortikosteroid und hpbcd zur behandlung oder prävention einer entzündungskrankheit durch nasale verabreichung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054736A (en) * 1970-06-10 1977-10-18 Ono Pharmaceutical Co., Ltd. Clathrate compounds of prostaglandins or their analogues with cyclodextrin
JPS62123132A (ja) * 1985-11-21 1987-06-04 Michio Nakanishi 気管支喘息治療用組成物
JPS62292719A (ja) * 1986-06-12 1987-12-19 Kaken Pharmaceut Co Ltd 外用澄明水溶性製剤
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
US5840713A (en) * 1995-04-03 1998-11-24 Weisz; Paul B. Therapy for tissue membrane insufficiency
JP2001503406A (ja) * 1996-10-28 2001-03-13 ファーマーク、ニーダーランド、ベスローテン、フェンノートシャップ 医薬組成物
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk ＩｇＥ抗体抑制剤および食品

Also Published As

Publication number Publication date
US20110028432A1 (en) 2011-02-03
EP1799231A1 (de) 2007-06-27
ES2340511T3 (es) 2010-06-04
DE602005019247D1 (de) 2010-03-25
EP1655034A1 (de) 2006-05-10
US7829550B2 (en) 2010-11-09
EP1799231B1 (de) 2010-02-03
JP2008515847A (ja) 2008-05-15
ATE456955T1 (de) 2010-02-15
PL1799231T3 (pl) 2010-07-30
WO2006037769A1 (en) 2006-04-13
US20090012041A1 (en) 2009-01-08
US20120295872A1 (en) 2012-11-22

Similar Documents

Publication Publication Date Title
US20120295872A1 (en) Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases
US10799599B2 (en) Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
EP1732512B1 (de) Sulfoalkylethercyclodextrin und corticosteroid enthaltende inhalationsstofformulierung
US20070020196A1 (en) Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
RU2722414C2 (ru) Композиции на основе циклодекстрина и производного будесонида и способы их получения
US20150258133A1 (en) Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases
KR100771411B1 (ko) 피리미딘-2,4,6-트리온의 시클로덱스트린 포접 복합체
JP7008097B2 (ja) シクロデキストリン及びブデソニド誘導体組成物ならびに方法
JP4584981B2 (ja) 気管支炎症疾患の処置および予防のためのトリオキソピリミジンの使用
AU2011235943B2 (en) Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080328

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110628

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110928

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120424

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120427

R150 Certificate of patent or registration of utility model

Ref document number: 4989481

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150511

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees